Related Experiment Videos
PrP(Sc) typing by N-terminal sequencing and mass spectrometry
1Division of Neuropathology, Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
Archives of Virology. Supplementum
|February 24, 2001
Summary
Human prion diseases like Fatal Familial Insomnia (FFI) and Creutzfeldt-Jakob disease (CJD) show distinct abnormal prion protein (PrP(Sc)) structures. Identifying protease cleavage sites reveals unique PrP(Sc) conformers, aiding disease classification.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Human prion diseases exhibit diverse clinicopathological phenotypes.
- Phenotypic heterogeneity correlates with distinct abnormal prion protein (PrP(Sc)) forms.
- Previous studies differentiated PrP(Sc) in FFI and D178N CJD via gel mobility post-proteinase K (PK) treatment.
Purpose of the Study:
- To structurally characterize PrP(Sc) in familial prion diseases.
- To identify specific protease cleavage sites within PrP(Sc) from affected brains.
Main Methods:
- N-terminal sequencing of PrP(Sc).
- Mass spectrometry to determine protease cleavage sites.
- Analysis of PrP(Sc) from brain tissue of FFI, D178N CJD, and P102L GSS patients.
Main Results:
- Identified distinct main PK cleavage sites for PrP(Sc).
- Cleavage site at residue 97 in FFI.
- Cleavage site at residue 82 in D178N CJD and P102L GSS.
Conclusions:
- Differential protease accessibility indicates distinct PrP(Sc) conformers.
- PrP(Sc) exists in unique structural forms depending on the disease state.
- These structural differences contribute to the heterogeneity of human prion diseases.